Evidence map›Paper›PMID 29736774›Full record

ArticleHandbook of experimental pharmacology2018

The Cerebellar GABA

David J Rossi, Ben D Richardson

Abstract read
In one paragraph

Article in Handbook of experimental pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Pharmacological targeting of the GABAAddiction biology · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

David J RossiDepartment of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, WA, USA. david.rossi@wsu.edu.
Ben D RichardsonDepartment of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
University of Idaho · USWashington State University · US

Funding

NEUROSTEROID MODULATION OF ETHANOL WITHDRAWAL SEVERITYR01AA012439 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI FINN, DEBORAH A., ROSSI, DAVID J · 2000 to 2017
$4.6M
Cerebellar Contributions to Alcohol Use DisordersR01AA026078 · NIAAA · WASHINGTON STATE UNIVERSITY · PI ROSSI, DAVID J · 2017 to 2021
$1.7M
NIAAA NIH HHS R01 AA012439NIAAA NIH HHS R01 AA026078
6 · The paper itself

Abstract

In the brain, fast inhibitory neurotransmission is mediated primarily by the ionotropic subtype of the gamma-aminobutyric acid (GABA) receptor subtype A (GABA

Indexed as

Alcohol-Related DisordersCerebellumEthanolGABA-A Receptor Antagonistsgamma-Aminobutyric AcidHumansReceptors, GABA-AEthanolGABA-A Receptor Antagonistsgamma-Aminobutyric AcidReceptors, GABA-AAddictionAlcoholAUDCerebellumEthanolGABA

Identifiers

PMID29736774
PMCPMC6222009
OpenAlexW2800331244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.